SEC Form 4 · accession 0001104659-16-129526
SYNERGY PHARMACEUTICALS, INC. · SGYP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Troy Hamilton
Officer — EVP and CCO
Period of report
Jun 24, 2016
Accepted (ET)
Jun 27, 2016 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001347613
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $3.67 | Jun 24, 2016 | A | 300,000 | A | — | Jun 24, 2026 | Common Stock | 300,000 | 675,000 | D |
Explanation of responses
- F1100,000 of the stock options vest on 6/24/2017, 2018 and 2019.